Provided by Tiger Trade Technology Pte. Ltd.

Larimar Therapeutics, Inc.

3.12
-0.4300-12.11%
Post-market: 3.210.0900+2.88%18:16 EST
Volume:2.73M
Turnover:9.05M
Market Cap:267.04M
PE:-1.60
High:3.56
Open:3.56
Low:3.12
Close:3.55
52wk High:6.91
52wk Low:1.61
Shares:85.59M
Float Shares:45.15M
Volume Ratio:1.47
T/O Rate:6.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9534
EPS(LYR):-1.3159
ROE:-78.24%
ROA:-42.99%
PB:1.92
PE(LYR):-2.37

Loading ...

Larimar Therapeutics Announces Positive Long-Term Study Results for Nomlabofusp in Friedreich’s Ataxia, Targets Accelerated FDA Approval in 2026

Reuters
·
Sep 29

Larimar Therapeutics Inc - Bla Submission for Accelerated Approval Targeted in Q2 2026

THOMSON REUTERS
·
Sep 29

Larimar Shares Rise on Plans to Share Friedreich's Ataxia Treatment Data

Dow Jones
·
Sep 29

Larimar Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 14

BRIEF-Larimar Therapeutics Q2 Net Income USD -26.182 Million

Reuters
·
Aug 14

Larimar Therapeutics Q2 EPS USD -0.41

THOMSON REUTERS
·
Aug 14

James E. Flynn, Director, Reports Acquisition of Common Shares of Larimar Therapeutics Inc

Reuters
·
Aug 05

Larimar Therapeutics Inc : Jonestrading Cuts Target Price to $10 From $12

THOMSON REUTERS
·
Aug 04

Larimar Therapeutics Inc expected to post a loss of 48 cents a share - Earnings Preview

Reuters
·
Aug 01

Larimar Therapeutics Inc. Files Prospectus for Public Offering, Raising Approximately $64.4 Million

Reuters
·
Jul 31

BUZZ-U.S. STOCKS ON THE MOVE-Electronic Arts, AEP, Peloton Interactive

Reuters
·
Jul 31

BUZZ-U.S. STOCKS ON THE MOVE-Apple, Hershey, Wingstop

Reuters
·
Jul 30

BUZZ-U.S. STOCKS ON THE MOVE-Visa, Kraft Heinz, Humana

Reuters
·
Jul 30

BRIEF-Larimar Therapeutics Prices Public Offering at $3.20 Per Share

Reuters
·
Jul 30

Larimar Therapeutics Inc - Prices Public Offering at $3.20 per Share

THOMSON REUTERS
·
Jul 30

Larimar Therapeutics Announces Pricing of Underwritten Public Offering

THOMSON REUTERS
·
Jul 30

Larimar Therapeutics Inc. Reports Preliminary Cash Holdings of $138.5 Million for Q2 2025

Reuters
·
Jul 30

BUZZ-Larimar Therapeutics falls on stock offering launch

Reuters
·
Jul 30

Larimar Therapeutics - Leerink Partners and Guggenheim Securities Are Joint Bookrunning Managers for Offering

THOMSON REUTERS
·
Jul 30

Larimar Therapeutics Inc - Grants Underwriters Option to Buy 15% More Securities

THOMSON REUTERS
·
Jul 30